Literature DB >> 2920742

Myocardial 201Tl washout after combined dipyridamole submaximal exercise stress: reference values from different patient groups.

L Fridrich1.   

Abstract

Dipyridamole stress is favorable in patients unable to exercise maximally for 201Tl myocardial scintigraphy. Aside from an analysis of uptake defects, proper washout analysis can be limited by heart rate variations when isolated dipyridamole stress is used. Heart rate standardized 201Tl washout kinetics after a combined dipyridamole and submaximal exercise stress protocol (CDSE), feasible in elderly patients as well as in patients with peripheral artery disease, were therefore studied to investigate the 201Tl washout after CDSE in differently defined patient groups: Group I comprised 19 patients with documented heart disease and angiographically excluded coronary artery disease (CAD); group II contained 17 patients with a very low likelihood of CAD determined by both normal exercise radionuclide ventriculography and normal 201Tl uptake. Group III comprised 56 patients with a 50% pretest likelihood of CAD but normal 201Tl uptake. Mean washout values were nearly identical in all groups. Despite similar uptake patterns, however, washout standardized by CDSE was significantly lower than the normal washout values after maximal treadmill exercise. Thus an obviously lower 201Tl washout after CDSE than after maximal treadmill exercise must be considered if washout analysis criteria after dipyridamole are applied to evaluate ischemic heart disease. Nevertheless, heart rate elevation achieved by additional submaximal exercise stress seems necessary, adequate and clinically safe for standardisation of washout analysis in dipyridamole 201Tl scintigraphy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920742     DOI: 10.1007/BF00702624

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  29 in total

Review 1.  Thallium-201 myocardial scintigraphy.

Authors:  A S Iskandrian; A H Hakki
Journal:  Am Heart J       Date:  1985-01       Impact factor: 4.749

2.  Clinical decision making: dipyridamole thallium imaging.

Authors:  J B Gill; D D Miller; C A Boucher; H W Strauss
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

3.  Resting kinetics of thallium-201 in patients with coronary artery disease.

Authors:  A S Iskandrian; A H Hakki; A Amenta; S A Kane; S Mattleman; D Edlin
Journal:  Chest       Date:  1984-08       Impact factor: 9.410

4.  Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial.

Authors:  P C Albro; K L Gould; R J Westcott; G W Hamilton; J L Ritchie; D L Williams
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

5.  Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease.

Authors:  A Nitenberg; J M Foult; A Kahan; J Perennec; J Y Devaux; C J Menkes; B Amor
Journal:  Am Heart J       Date:  1986-08       Impact factor: 4.749

6.  Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease.

Authors:  B G Brown; M A Josephson; R B Petersen; C D Pierce; M Wong; H S Hecht; E Bolson; H T Dodge
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

7.  Regional myocardial blood flow in man during dipyridamole coronary vasodilation.

Authors:  S G Sorensen; B M Groves; L D Horwitz; T K Chaudhuri
Journal:  Chest       Date:  1985-06       Impact factor: 9.410

8.  Space/time quantitation of thallium-201 myocardial scintigraphy.

Authors:  E Garcia; J Maddahi; D Berman; A Waxman
Journal:  J Nucl Med       Date:  1981-04       Impact factor: 10.057

9.  Dipyridamole combined with exercise for thallium-201 myocardial imaging.

Authors:  P R Walker; M A James; R P Wilde; C H Wood; J R Rees
Journal:  Br Heart J       Date:  1986-04

10.  A format for integrating the interpretation of exercise ejection fraction and wall motion and its application in identifying equivocal responses.

Authors:  A Rozanski; G A Diamond; R Jones; J S Forrester; D Berman; D Morris; B H Pollock; M Freeman; H J Swan
Journal:  J Am Coll Cardiol       Date:  1985-02       Impact factor: 24.094

View more
  1 in total

1.  Dipyridamole combined with symptom-limited exercise for myocardial perfusion scintigraphy: image characteristics and clinical role.

Authors:  G A Hurwitz; J E Powe; A A Driedger; K J Finnie; N R Laurin; A C MacDonald
Journal:  Eur J Nucl Med       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.